| Name | N-[(1R,6R)-6-amino-2,2-difluorocyclohexyl]-5-methyl-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]thiophene-2-carboxamide |
|---|
| Description | MARK-IN-1 is a potent microtubule affinity regulating kinase (MARK) inhibitor with an IC50 of <0.25 nM. |
|---|---|
| Related Catalog | |
| Target |
IC50: <0.25 nM (MARK)[1] |
| In Vitro | MARK-IN-1 (Compound 25) is a potent MARK inhibitor. Inhibition of MARK represents a potentially attractive means of arresting neurofibrillary tangle pathology in Alzheimer's disease[1]. |
| References |
| Molecular Formula | C22H23F2N7OS |
|---|---|
| Molecular Weight | 471.52600 |
| Exact Mass | 471.16500 |
| PSA | 131.37000 |
| LogP | 4.50280 |